Nuclear Degradation in the Lens, circa 1897-1899

By Ralf Dahm Nuclear Degradation in the Lens, circa 1897–1899 The developing lens (progressing left to right in the top line, then left to right in the bottom line) invaginates from the surface and pinches off as a hollow vesicle. The remaining cells then elongate to fill the vesicle and form a solid lens. Finally, the cells in the center of the lens degrade their nuclei and other organelles. Courtesy of Zeitschrift für wissensch

Written byRalf Dahm
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

In 1851, the Swiss anatomist Hermann Meyer dissected the eyes of a newborn dog and noticed that the cells at the center of the lens lacked nuclei. This observation and subsequent similar findings were little more than a curiosity for nearly half a century. Between 1897 and 1899, however, the Austrian anatomist Carl Rabl published a series of seminal papers in which he described the embryonic development and adult morphology of the lens in great detail. Rabl, then working at the German Karl-Ferdinands University in Prague, systematically analyzed the lenses of dozens of vertebrate species, including kiwi birds, chameleons, martens, alligators, chamois, bats, rays, and axolotls, among the more exotic.

In his work, he demonstrated that the nuclei begin to degrade at a precise point in lens cell differentiation. Nuclei first round up and shrink, the chromatin then condenses into large clumps, and, finally, all the nuclei in the center ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies